WJPPS Citation

Login

Search

News & Updation

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

  • WJPPS: JULY ISSUE PUBLISHED
  • JULY 2026 Issue has been successfully launched on 1 JULY 2026.

Abstract

DEVELOPMENT AND EVALUATION OF SMART PH-RESPONSIVE BUDESONIDE LOADED NANOPARTICLES FOR TARGETED DELIVERY IN INFLAMMATORY BOWEL DISEASE (IB)

Velmurugan T.*, Dr. M. Senthilraja, Dr. Pitta Sriramcharan

ABSTRACT

Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis and Crohn’s disease, represents a chronic and relapsing inflammatory condition of the gastrointestinal tract that necessitates site-specific therapeutic intervention. Conventional budesonide formulations are hindered by poor bioavailability, premature drug release, and systemic adverse effects. The present investigation was undertaken to develop and evaluate a smart pH-responsive nanoparticulate system for the targeted colonic delivery of budesonide, aiming to enhance therapeutic efficacy while minimizing systemic exposure. Nanoparticles were formulated using pH-sensitive polymers such as Eudragit® S100, chitosan, and alginate, and optimized for particle size, zeta potential, encapsulation efficiency, and stability. Characterization by Fourier Transform Infrared Spectroscopy (FTIR) and Differential Scanning Calorimetry(DSC) confirmed drug–polymer compatibility, while Scanning Electron Microscopy (SEM) demonstrated uniform, spherical morphology. In vitro release studies under simulated gastrointestinal conditions exhibited negligible drug release in acidic pH and sustained release at colonic pH, confirming pH-dependent responsiveness. Ex vivo studies revealed enhanced mucosal adhesion and drug retention in colonic tissue. The optimized formulation significantly improved local drug availability and reduced systemic corticosteroid exposure. Overall, the developed pH-responsive budesonide-loaded nanoparticles present a promising, patient-compliant, and efficacious platform for targeted drug delivery in the management of Inflammatory Bowel Disease.

Keywords: Budesonide; pH-responsive nanoparticles, colon-targeted drug delivery, Inflammatory Bowel Disease (IBD), Eudragit® S100, chitosan, alginate, controlled release, site-specific delivery, nanotechnology.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More